Table 2.
Factor | Adjusted odds ratio (95% CI) | p-value |
---|---|---|
Age at diagnosis | 1.00 (0.98, 1.02) | 0.733 |
Severity (PTA) at baseline | 0.98 (0.96, 1.00) | 0.103 |
Etiologic factors | ||
ENT anomaly-external/middle ear | 0.01 (0.00, 0.13) | <0.001 |
ENT anomaly-inner ear | 0.08 (0.01, 0.98) | 0.049 |
Syndrome (associated with HL) | 0.08 (0.01, 0.93) | 0.044 |
Hereditary/genetic | 0.05 (0.00, 0.71) | 0.026 |
CMVa | n/a | n/a |
CMV, cytomegalovirus; ENT, ear, nose, throat; HL, hearing loss; PTA, pure-tone average.
Insufficent number of participants for the regression model; 1 of 8 with CMV had stable hearing loss.